PT301US Airvo 3 Respiratory Support Device with software version 1.2.0 and/or 1.5.1 The Airvo...
FDA Device Recall #Z-3262-2024 — Class II — August 7, 2024
Recall Summary
| Recall Number | Z-3262-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 7, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Fisher & Paykel Healthcare, Ltd. |
| Location | Auckland |
| Product Type | Devices |
| Quantity | 944 units |
Product Description
PT301US Airvo 3 Respiratory Support Device with software version 1.2.0 and/or 1.5.1 The Airvo 3 is intended to provide high flow warmed and humidified respiratory gases for administration to spontaneously breathing infant, child, adolescent and adult patients in hospitals and sub-acute facilities.
Reason for Recall
Due to a software issue, affected devices that are set up with High Pressure Oxygen (HPO), if the flow alignment alarm occurs, the device will deliver room air only. If this happens, a patient my experience oxygen desaturation that could lead to hypoxia.
Distribution Pattern
U.S.: AZ, CA, CO, CT, DC, FL, GA, IA, IL, KY, MA, MD, MI, MN, MO, MT, ND, NH, NJ, NV, NY, OH, OR, PA, SD, TX, UT, VA and WA. O.U.S.: Not provided
Lot / Code Information
Model Number: PT301US UDI-DI code: 09420012466662 Lot/Serial Numbers:
Other Recalls from Fisher & Paykel Healthcare, Ltd.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0158-2026 | Class II | Airvo 2, REF: PT101US, and myAirvo 2, REF: PT10... | Sep 18, 2025 |
| Z-1823-2024 | Class II | Airvo 2 Humidifier, REF: PT101US, and myAirvo 2... | Apr 2, 2024 |
| Z-0210-2015 | Class II | Fisher and Paykel Healthcare (FPH) IW900-Series... | Nov 6, 2014 |
| Z-1539-2014 | Class I | Infant Nasal CPAP (continuous positive airway p... | Apr 15, 2014 |
| Z-1437-2013 | Class II | Fisher & Paykel Healthcare ICON CPAP (continuo... | Apr 22, 2013 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.